Clinical Research Directory
Browse clinical research sites, groups, and studies.
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
Sponsor: The University of Texas Medical Branch, Galveston
Summary
The study's purpose is to evaluate whether creatine supplementation can help breast cancer survivors respond quicker to exercise by improving strength, endurance, and body composition. We are seeking to compare information collected from healthy woman of the same age who have never had breast cancer to those participants who have had breast cancer and undergone chemotherapy treatment.
Official title: An Open-label Randomized Trial of Exercise ± Creatine Supplementation to Augment the Adaptations of Exercise Training in Cancer Survivors
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-10-29
Completion Date
2028-05-31
Last Updated
2025-12-24
Healthy Volunteers
Yes
Interventions
Creatine
Those randomized to receive creatine (experimental group) will be initially dosed at 20 g/day for 7 days to boost availability of creatine systemically. Thereafter, the dose will be reduced to 5 g/day for maintenance through the duration of the 12-week protocol.
Locations (1)
The University of Texas Medical Branch, Galveston
Galveston, Texas, United States